Peter Frampton kicked off his farewell tour last night (June 18th) in Tulsa, Oklahoma, hitting the stage once again at Number One. The legendary guitarist's latest album, titled All Blues, debuted at Number One on the Billboard Blues Albums chart.
Critics and fans are already whispering that Frampton's All Blues set is a shoe-in for several Grammy categories — reminding fans of the whirlwind ride of 2006's renowned Fingerprints collection, which scored the Humble Pie co-founder his first-ever Grammy for Best Pop Instrumental Album.
Frampton has been forced to say goodbye to the road upon discovering he's suffering from a degenerative muscle disease called Inclusion-Body Myosotis, that slowly weakens the body's muscles.
When pressed if this will be a sad goodbye to his live career, Frampton admitted: “I would think so. We're going to be playing The Forum (in L.A.) and We're going to be playing Madison Square Garden and I haven't played those in many, many years — and my kids are gonna be there. It'll be a sad occasion when the last date happens. I know that I'll be at the top of my game for this tour and I will make it through this and people won't be saying 'Oh, he can't play as good. . . ' I can, y'know? But, we just don't know for how long.”
Peter Frampton plays tomorrow night (June 20th) in Little Rock, Arkansas at Robinson Performance Hall.